Literature DB >> 32588124

[Unusual anisocoria].

Jan Klonner1, Daniel Salchow2.   

Abstract

A 53-year-old female patient presented with increased light sensitivity 3 weeks after oral intake of moxifloxacin tablets for an upper respiratory tract infection. The symptoms were anisocoria and the pupils did not react to light or accommodation. The examination of the anterior segment of the eye revealed extensive bilateral iris transillumination defects (ITD). We diagnosed a bilateral acute iris transillumination (BAIT) syndrome. The BAIT syndrome is a rare disorder associated with massive depigmentation of the iris and atrophy of the iris musculature. A risk factor for BAIT syndrome seems to be the oral intake of antibiotics, in particular moxifloxacin after an upper respiratory tract infection but cases of spontaneous occurrence have also been described. Middle-aged women are particularly affected. The exact cause of BAIT syndrome is so far unknown but a potential mechanism involves the concentration of the antibiotic in the vitreous body. Differential diagnoses include other causes for ITD, such as albinism, intraocular inflammation, pseudoexfoliation syndrome and pigment dispersion syndrome. To date there is no specific treatment for BAIT syndrome. Possible complications include increased light sensitivity and post-BAIT glaucoma. Knowledge of the rare BAIT syndrome can be useful in the clinical routine for the differential diagnostic classification of an anisocoria and can possibly contribute to avoidance of unnecessary diagnostic steps.

Entities:  

Keywords:  Anisocoria; BAIT-Syndrome; Fluoroquinolone; Iris-Transillumination; Upper respiratory tract infection

Mesh:

Substances:

Year:  2021        PMID: 32588124     DOI: 10.1007/s00347-020-01153-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  7 in total

1.  Bilateral acute depigmentation of the iris.

Authors:  Ilknur Tugal-Tutkun; Meri Urgancioglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-05       Impact factor: 3.117

2.  Bilateral uveitis associated with fluoroquinolone therapy.

Authors:  David M Hinkle; Mark S Dacey; Efrem Mandelcorn; Partho Kalyani; John Mauro; James H Bates; Sarkis H Soukasian; Gary N Holland; C Stephen Foster; Frederick T Fraunfelder; Janet L Davis; Frederick W Fraunfelder
Journal:  Cutan Ocul Toxicol       Date:  2011-10-08       Impact factor: 1.820

3.  Bilateral acute iris transillumination.

Authors:  Ilknur Tugal-Tutkun; Sumru Onal; Aylin Garip; Muhittin Taskapili; Haluk Kazokoglu; Sibel Kadayifcilar; Philippe Kestelyn
Journal:  Arch Ophthalmol       Date:  2011-10

4.  Is oral moxifloxacin associated with bilateral acute iris transillumination?

Authors:  Elke O Kreps; Kathy Hondeghem; Albert Augustinus; Celine Sys; Sara Van de Veire; Bart P Leroy; Pieter-Paul Schauwvlieghe
Journal:  Acta Ophthalmol       Date:  2017-10-25       Impact factor: 3.761

5.  Acute depigmentation of the iris: a retrospective analysis of 22 cases.

Authors:  Ankush Kawali; Padmamalini Mahendradas; Rohit Shetty
Journal:  Can J Ophthalmol       Date:  2018-05-21       Impact factor: 1.882

6.  Vitreous and aqueous penetration of orally and topically administered moxifloxacin.

Authors:  Masamichi Fukuda; Naoko Shibata; Hiromi Osada; Yoko Yamashiro; Hiroshi Sasaki
Journal:  Ophthalmic Res       Date:  2011-02-12       Impact factor: 2.892

Review 7.  Bilateral acute iris transillumination (BAIT) syndrome: literature review.

Authors:  Jean Marc Perone; Dimitri Chaussard; George Hayek
Journal:  Clin Ophthalmol       Date:  2019-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.